human embryonic kidney hek293 cells  (ATCC)

Journal: Journal of Sport and Health Science

Article Title: Exercise training-induced extracellular miR-136-3p modulates glucose uptake and myogenesis through targeting of NRDC in human skeletal muscle

doi: 10.1016/j.jshs.2025.101091

Figure Lengend Snippet: MiR-136-3p content in cell culture medium and uptake of extracellular miR-136-3p into cultured myotubes. MiRNA content in (A) human myotubes and (B) human pancreatic islets culture media. Results were first normalized using RNU1A1 and then presented in relation to miR-23a-3p content for n = 4 different donors for myotubes cultures and n = 4 donors for human islets. Left panel (C) shows bright-field image of cultured human myotubes and right panel (C) shows a representative fluorescence image of cultured human myotubes with cells exposed to human serum-derived EVs loaded with Cy3-miR-136-3p. Cy3 fluorescence (red) is detected in the whole cytoplasm of the human myotubes. (D) Representative fluorescence image of human myotubes exposed to HEK293 culture medium with EVs loaded with Cy3-miR-136-3p (red). (E) Representative image of human myotubes exposed to EVs loaded with TexasRed-labeled with a control RNA (orange). Nuclear Hoechst staining is shown in blue. Scale bar = 100 μm. EVs = extracellular vesicles; HEK293 = human embryonic kidney; miR = microRNA; Rel = relative; RNU1A1 = U1 small nuclear RNA.

Article Snippet: Human embryonic kidney (HEK293) cells were obtained from American Type Culture Collection (ATCC) and cultured in high-glucose (4.5 g/L) Dulbecco's Modified Eagle Medium (DMEM; Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% (vol/vol) FBS.

Techniques: Cell Culture, Fluorescence, Derivative Assay, Labeling, Control, Staining

Journal: Journal of Sport and Health Science

Article Title: Exercise training-induced extracellular miR-136-3p modulates glucose uptake and myogenesis through targeting of NRDC in human skeletal muscle

doi: 10.1016/j.jshs.2025.101091

Figure Lengend Snippet: NRDC is a direct target of miR-136-3p in human myotubes. Skeletal muscle NRDC mRNA is responsive to training and inactivity. (A) Tissue mRNA expression of NRDC from the Human Protein Atlas database showing enriched expression of NRDC in human skeletal muscle. (B) The miR-136-3p target site in the NRDC gene is highly conserved in mammals. (C) Luciferase activity in HEK293 cells co-transfected the NRDC 3’UTR and miR-136-3p with or without anti-miR136-3p inhibitors. miR-136-3p transfection downregulates NRDC (D) mRNA and (E) representative image of protein abundance in human myotubes. (F) Publicly available data ( GSE14413 ) showing NRDC mRNA expression in human skeletal muscle of healthy young participants after 6 weeks of endurance training ( n = 8). (G) Publicly available data ( GSE120862 ) showing NRDC mRNA expression in human skeletal muscle of healthy young participants after 2 months of aerobic training ( n = 10). (H) Publicly available data ( GSE14901 ) showing NRDC mRNA expression in human skeletal muscle of healthy young participants after 14 days of immobilization ( n = 24). * p < 0.05, ** p < 0.005. GSE = gene set enrichment; HEK293 = human embryonic kidney; miR = microRNA; NC = negative control; NRDC = nardilysin convertase; nTPM = normalized transcripts per million; si NRDC = small interfering RNA of NRDC ; UTR = untranslated region.

Article Snippet: Human embryonic kidney (HEK293) cells were obtained from American Type Culture Collection (ATCC) and cultured in high-glucose (4.5 g/L) Dulbecco's Modified Eagle Medium (DMEM; Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% (vol/vol) FBS.

Techniques: Expressing, Luciferase, Activity Assay, Transfection, Quantitative Proteomics, Negative Control, Small Interfering RNA

Journal: Communications Biology

Article Title: The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growth

doi: 10.1038/s42003-026-10272-2

Figure Lengend Snippet: a Endogenous protein levels of MYPOP in untreated cancer cell lines. Normal skin cells (NHEK) and normal lung cells (181576 N, 181652 N) served as controls. GAPDH or β-actin staining was used as loading control. b Cancer cells were transfected with either a MYPOP expression plasmid or a control plasmid, selected for 6–12 days with G418, fixed, and stained with crystal violet. The cell-covered area was quantified (relative area). Values are presented as mean + SD. The mean for control-transfected cells was set to 100% (dotted line). Statistical significance was determined by comparing control and MYPOP expressing cells with p = 0.0022 for Huh7 ( n = 3), p = 0.0028 for HEK293 ( n = 5), p = 0.0064 for MCF7 ( n = 4), p = 0.0294 for HCT116 ( n = 3), p = 0.0106 for HeLa ( n = 3), p = 0.0003 for A549 ( n = 3), and p = 0.0026 for 2106 T ( n = 4).

Article Snippet: Human hepatocellular carcinoma cell line Huh7 was provided by Dr. Reinhild Prange, human breast adenocarcinoma cell line MCF7 by Dr. Walburgis Brenner, colorectal cell line HCT116 by Dr. Thomas Kindler, (all University Medical Center, Mainz, Germany), and human embryonic kidney 293 (HEK293) cells were obtained from ATCC (CRL-1573).

Techniques: Staining, Control, Transfection, Expressing, Plasmid Preparation

Journal: bioRxiv

Article Title: Rap1b Activates Endosomal AC9 to Drive the Second cAMP Wave

doi: 10.64898/2026.05.06.723328

Figure Lengend Snippet: (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a domain. HEK293 cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).

Article Snippet: The rat hepatoma clonal cell line HC–1 (kindly provided by Dr. Elliot Ross, University of Texas Southwestern Medical Center), human embryonic kidney WT HEK–293 cells (ATCC CRL–1573; Manassas, VA), and HEK–293 ΔGαs (kindly provided by Asaka Inoue, Tohoku University, Japan) cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; MT10013CM) supplemented with 10% fetal bovine serum (FBS; FB12999102), penicillin plus streptomycin (100 IU/mL and 100 μg/mL, respectively; 15140122), and L–glutamine (2 mM; 25030164) (All from Thermo Fisher Scientific).

Techniques: Immunofluorescence, Blocking Assay, Expressing, Over Expression, Knockdown, Microscale Thermophoresis, Binding Assay, Purification, In Vitro, Pull Down Assay, Transfection, Incubation, Western Blot, Plasmid Preparation, Control